BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

eMed Future

Headquartered in Columbus, Ohio, E Med Future manufactures and markets a revolutionary needle destruction device, NeedleZap®, developed specifically to help reduce accidental needlestick injuries in the workplace. When a used hypodermic needle is inserted into the unit, the patented electrode system completely disintegrates the needle in approximately two seconds at 2200oF, leaving the syringe intact. NeedleZap® is portable, rechargeable and can accommodate a wide range of needle gauges. With the March 14, 2003 approval order from the FDA, E Med can market NeedleZap® to an extensive audience base that includes (but not limited to) physicians, hospitals/clinics, home healthcare providers, long term care facilities, dental care professionals, veterinary facilities, law enforcement professionals, hospitality venues, the military and homeland security personnel. The company currently has worldwide distribution agreements with American Health & Safety Products, Inc., and their wholly owned subsidiary AHSP International L.L.C., who have representation in the United States, Europe, China, South America, Central America and Canada. E Med Future is a publicly traded company. E Med completed a reverse merger with Las Vegas-based Micro-Economics, Inc. on April 17, 2003. Concurrent with the merger, the surviving company retained the E Med Future, Inc. name and changed its trading symbol to EMDF.OB. The company’s common stock began trading that same day on the NASDAQ Over-the-Counter Bulletin Board. The company plans to continue its focus on bringing new products to the marketplace through its own internal research and development efforts, as well as through acquisitions and licensing of new products from a broad array of external sources. On June 17, 2003, E Med announced the signing of a strategic alliance agreement with UTEK Corporation (AMEX: UTK), an innovative technology transfer company. UTEK will identify and evaluate new university and federal laboratory technologies that compliment E Med’s business strategies.


Contact Details:
794 Morrison Road, Suite 911
Columbus
Ohio
43230
United States of America
Tel:1-330-674-1363
Fax:
Email:info@needlezap.com
WWW:

www.needlezap.com




Loading...

BioNews Results for eMed Future:

Debating PCI-Related Delays and the Management of STEMI Patients
Medscape:  Oct 3 2008 8:45PM Matching: em future
Get a Deep Insight Into the World Blood Gas & Electrolyte Analyzers Market
Reuters:  Oct 1 2008 7:22PM Matching: em future
Examine the World Imaging Agents (Contrast Media, Radiopharmaceuticals) Market
Marketwire via Yahoo!:  Sep 18 2008 9:23AM Matching: em future
On the beat: Voci's cancer survivors giving back
Canton Repository:  Sep 7 2008 12:49PM Matching: em future
Learn about the World CNS Therapeutics Market
Macro World Investor:  Sep 4 2008 11:09PM Matching: em future
Promote your company here: BioNewsCast - Press Release Distribution

View more eMed Future news.

eMed Future (EMDF.OB) Financial information Links from Barchart

EMDF.OB Quote from from Barchart.com
EMDF.OB Chart from from Barchart.com
EMDF.OB Profile from from Barchart.com
EMDF.OB Opinion from from Barchart.com

View more eMed Future finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 158 times since April 2007, the link to the organisation's website has been followed 32 times

Recent Search Terms used to find this page: e med future 2008 | Needlezap | .

Search for more companies in Columbus

Search for more companies in Ohio



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for eMed Future
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.